XOMA Corp (XOMA)
25.51
-0.15
(-0.58%)
USD |
NASDAQ |
May 17, 16:00
25.34
-0.17
(-0.67%)
After-Hours: 20:00
XOMA Research and Development Expense (Quarterly): 0.033M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.033M |
| December 31, 2023 | 0.025M |
| September 30, 2023 | 0.025M |
| June 30, 2023 | 0.039M |
| March 31, 2023 | 0.054M |
| December 31, 2022 | 0.028M |
| September 30, 2022 | 0.029M |
| June 30, 2022 | 0.04M |
| March 31, 2022 | 0.056M |
| December 31, 2021 | 0.042M |
| September 30, 2021 | 0.03M |
| June 30, 2021 | 0.038M |
| March 31, 2021 | 0.061M |
| December 31, 2020 | 0.036M |
| September 30, 2020 | 0.034M |
| June 30, 2020 | 0.038M |
| March 31, 2020 | 0.062M |
| December 31, 2019 | 0.13M |
| September 30, 2019 | 0.143M |
| June 30, 2019 | 0.724M |
| March 31, 2019 | 0.256M |
| December 31, 2018 | 0.237M |
| September 30, 2018 | 0.637M |
| June 30, 2018 | 0.376M |
| March 31, 2018 | 0.432M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.66M |
| September 30, 2017 | 0.307M |
| June 30, 2017 | 2.916M |
| March 31, 2017 | 3.993M |
| December 31, 2016 | 8.248M |
| September 30, 2016 | 8.674M |
| June 30, 2016 | 13.70M |
| March 31, 2016 | 13.61M |
| December 31, 2015 | 13.60M |
| September 30, 2015 | 17.56M |
| June 30, 2015 | 19.69M |
| March 31, 2015 | 20.00M |
| December 31, 2014 | 19.38M |
| September 30, 2014 | 20.24M |
| June 30, 2014 | 19.59M |
| March 31, 2014 | 21.55M |
| December 31, 2013 | 22.95M |
| September 30, 2013 | 18.20M |
| June 30, 2013 | 17.07M |
| March 31, 2013 | 16.64M |
| December 31, 2012 | 15.76M |
| September 30, 2012 | 18.41M |
| June 30, 2012 | 18.44M |
| March 31, 2012 | 15.77M |
| December 31, 2011 | 16.66M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.025M
Minimum
Sep 2023
0.724M
Maximum
Jun 2019
0.0833M
Average
0.0385M
Median
Research and Development Expense (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | -- |
| AbbVie Inc | 1.939B |
| AnaptysBio Inc | 37.04M |
| Kinnate Biopharma Inc (DELISTED) | 13.37M |
| NovaBay Pharmaceuticals Inc | 0.019M |